Firvanq Kit
NDC Package 65628-206-05

11-digit billing NDC: 65628020605 · Billing unit: ML

Package Information

Firvanq (vancomycin hydrochloride) kits is fIRVANQ is indicated for the treatment of Clostridium difficile‑associated diarrhea in adults and pediatric patients less than 18 years of age. This formulation utilizes a kit delivery system. Marketed by Azurity Pharmaceuticals, Inc, this product is identified by NDC 65628-206 and is authorized under FDA application NDA208910.

Identification & Billing

NDC Package Code
65628-206-05
Package Description
1 KIT in 1 CARTON * 7.5 g in 1 BOTTLE * 145 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
65628020605
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Firvanq
Non-Proprietary Name
Vancomycin Hydrochloride
Dosage Form
Kit - A packaged collection of related material.
Usage Information
FIRVANQ is indicated for the treatment of Clostridium difficile‑associated diarrhea in adults and pediatric patients less than 18 years of age. FIRVANQ is also indicated for the treatment of enterocolitis caused by Staphylococcus aureus(including methicillin‑resistant strains) in adults and pediatric patients less than 18 years of age. Important Limitations of UseParenteral administration of vancomycin is not effective for the above infections; therefore, vancomycin must be given orally for these infections.Orally administered vancomycin hydrochloride is not effective for treatment of other types of infections.To reduce the development of drug‑resistant bacteria and maintain the effectiveness of FIRVANQ and other antibacterial drugs, FIRVANQ should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Regulatory & Marketing

Labeler Name
Azurity Pharmaceuticals, Inc
Product Type
Human Prescription Drug
FDA Application #
NDA208910
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-26-2018
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65628-206-05 identifies a specific commercial package of 1 kit in 1 carton * 7.5 g in 1 bottle * 145 ml in 1 bottle of Firvanq, a human prescription drug labeled by Azurity Pharmaceuticals, Inc. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Azurity Pharmaceuticals, Inc on January 26, 2018. The current certification is valid through December 31, 2027.

How is this Azurity Pharmaceuticals, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65628020605. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65628-206-05
11-Digit CMS (5-4-2)
65628-0206-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.